EYEG - Eyegate Pharmaceuticals reports Q1 results
Eyegate Pharmaceuticals (EYEG): Q1 Net loss of $2.58M.Cash and cash equivalents of $6.61M.Press Release
For further details see:
Eyegate Pharmaceuticals reports Q1 resultsLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Eyegate Pharmaceuticals Inc. |
| Stock Symbol: | EYEG |
| Market: | NASDAQ |
Get EYEG Alerts
News, Short Squeeze, Breakout and More Instantly...